Stratified medicine in schizophrenia : how accurate would a test of drug response need to be to achieve cost-effective improvements in quality of life?
Year of publication: |
2019
|
---|---|
Authors: | Jin, Huajie ; McCrone, Paul ; MacCabe, James H. |
Published in: |
The European journal of health economics : HEPAC ; health economics in prevention and care. - Berlin : Springer, ISSN 1618-7598, ZDB-ID 2045253-6. - Vol. 20.2019, 9, p. 1425-1435
|
Subject: | Schizophrenia | Stratified medicine | Health economics | Cost-effectiveness | Markov model | Arzneimittel | Pharmaceuticals | Lebensqualität | Quality of life | Gesundheitsökonomik | Kosten-Wirksamkeits-Analyse | Cost-effectiveness analysis | Gesundheitswesen | Health care system | Gesundheitsversorgung | Health care | Gesundheitskosten | Health care costs | Psychische Krankheit | Mental disorder |
-
Schwander, Bjoern, (2014)
-
Santini, Ziggi Ivan, (2021)
-
Conditional approval and value-based pricing for new health technologies
Yapar, Ozge, (2024)
- More ...
-
Wijnen, Ben F. M., (2018)
-
Mosweu, I., (2017)
-
Rubio-Valera, Maria, (2019)
- More ...